Kaja Kostyrko
7PUBLICATIONS
54CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Nov 25, 2025
SOS1 inhibition suppresses the emergence of osimertinib resistance to generate a durable response in EGFR-mutant lung cancer.Brianna R Daley, Patricia L Theard, Jacob M Hughes
|Oct 22, 2024
SOS1 Inhibition Enhances the Efficacy of KRASG12C Inhibitors and Delays Resistance in Lung Adenocarcinoma.Brianna R Daley, Nancy E Sealover, Bridget A Finniff
|Aug 05, 2024
Co-targeting SOS1 enhances the antitumor effects of KRASG12C inhibitors by addressing intrinsic and acquired resistance.Venu Thatikonda, Hengyu Lyu, Sabine Jurado
|May 10, 2024
Reshaping the Tumor Microenvironment of KRASG12D Pancreatic Ductal Adenocarcinoma with Combined SOS1 and MEK Inhibition for Improved Immunotherapy Response.Robert J Norgard, Pratha Budhani, Sarah A O'Brien
|Dec 18, 2023
SOS1 inhibition enhances the efficacy of and delays resistance to G12C inhibitors in lung adenocarcinoma.Brianna R Daley, Nancy E Sealover, Erin Sheffels
|Jul 05, 2023
UHRF1 is a mediator of KRAS driven oncogenesis in lung adenocarcinoma.Kaja Kostyrko, Marta Román, Alex G Lee
Pageof 2
Frequent Collaborators
4 joint publications
Marco H Hofmann
3 joint publications
Robert L Kortum
2 joint publications
Daniel Gerlach
2 joint publications
Bridget A Finniff
2 joint publications
Jacob M Hughes
2 joint publications
Brianna R Daley
2 joint publications
Clifton L Dalgard
2 joint publications
Melanie Hinkel
1 joint publications
Edwin E Jeng
1 joint publications
Peter K Jackson
